Moffitt Study Finds Promising First Evidence of Targeted Therapy for NRAS-Mutant Melanoma

Researchers uncover a new way to help the immune system fight aggressive skin cancer

Moffitt Studies Uncover Complementary Strategies to Overcome Resistance to KRAS G12C Inhibitors in Lung Cancer

RAS proteins control cell growth. When stuck “on,” they fuel tumors, but new drugs may flip the switch back off.

Moffitt Cancer Center and Dyve Biosciences Partner To Advance First-in-Human Studies Targeting Tumor Acidity

Five-year, multi-study partnership leverages Moffitt’s expedited trial infrastructure and regulatory expertise to accelerate DYV800 development in...

Pentecost Foundation Donates Another $10 Million to Moffitt Cancer Center, Fueling Unprecedented Push Toward a Myeloma Cure

The Pentecost family makes $10 million donation for multiple myeloma

Moffitt Study Shows Gene Expression Test Can Help Identify Melanoma Patients at Low Risk of Lymph Node Spread

Results show test can help guide decisions about sentinel lymph node biopsy, reducing unnecessary procedures for patients

CancerX Unveils New Leadership Model to Strengthen Cancer Innovation Community

Advocate Health and Moffitt Cancer Center to anchor new consortium-based model

AccelerOnc, Nation’s First Venture Studio for Digital Oncology, Unveils Portfolio

Launched by Moffitt Cancer Center, the initiative leverages clinical expertise to develop global cancer solutions

Moffitt Cancer Center Partners with AbbVie to Advance New Cancer Treatments

Five-year strategic alliance is designed to accelerate clinical innovation in lung cancer and multiple myeloma

Moffitt Cancer Center Receives $22.4 Million Grant to Advance Research and Clinical Trials for Leptomeningeal Disease

New funding supports innovative treatments for a little-understood and often fatal complication of breast cancer

Moffitt Study Shows Promise for New Treatment in Patients With Leptomeningeal Disease

Avelumab combined with whole brain radiotherapy shows safety and potential survival benefit for patients with the disease

Moffitt Study Supports Gene-Tailored Radiation Doses To Treat HPV-Positive Throat Cancer

Genomic model shows promise in tailoring radiation doses, potentially reducing side effects without compromising cure rates

Moffitt Cancer Center Launches AccelerOnc Studio, First U.S. Venture Studio for Oncology

Initiative bridges clinical expertise and startup innovation to advance cancer care

Moffitt Cancer Center and Mainsail Lodging & Development Announce Partnership To Develop Full-Service Hotel on Moffitt’s McKinley Campus

$84 million project is anticipated to open in the summer of 2028

Moffitt Cancer Center Recognized as a 2025 Best and Brightest Company to Work for in the Nation

The cancer center has been recognized on the list for the past decade

Moffitt Researchers Develop Machine Learning Model to Predict Urgent Care Visits for Lung Cancer Patients

Incorporating patient-reported outcomes and wearable sensor data significantly improved prediction accuracy

News Releases